Shingo Takano. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useBevacizumab/therapeutic useCentral Nervous System Neoplasms/drug therapyCentral Nervous System Neoplasms/pathologyClinical Trials as TopicGlioma/drug therapyHumansRecurrence
Substances: See more » Angiogenesis InhibitorsBevacizumab
Year: 2016 PMID: 27459747
Source DB: PubMed Journal: Gan To Kagaku Ryoho ISSN: 0385-0684